BIOL 405 Lecture 9 | 05/29/2026

Cis-Dominance and Operator Mutations

  • Concept of Cis-Dominance: In the study of the lac operon, certain mutations are described using terms derived from Latin: "cis" and "trans."

  • The $O^C$ Mutant: This refers to the constitutive operator mutation. The transcript identifies this as "constituted butane" (likely an error for constitutive/mutant), which manifests as a cis-dominant effect.

    • It only affects the DNA sequence on which it is physically located (cis-acting).
    • The term "dominating cease" refers to the "cis-dominant" nature of these operator mutations.

  • Distinction from Trans-Dominance: Unlike some protein-based mutations (like the lac repressor), the $O^C$ mutation does not affect other DNA molecules in the same cell; it is strictly limited to its specific "chain" or DNA strand.

The $lacI^t$ Mutant and Synthetic Inducers

  • Introduction of $lacI^t$: This is a specific type of mutant repressor protein that differs from other known mutants (like "thirty one").

  • Binding Characteristics: The $lacI^t$ mutant protein binds significantly more tightly to synthetic inducers compared to standard repressor proteins.

  • Synthetic Inducer: IPTG:

    • IPTG (Isopropyl $\beta$-D-1-thiogalactopyranoside) is used as a synthetic inducer.
    • It is an analog of "iodolactone" (likely referring to allolactose, the natural inducer).
    • Because of its high affinity for $lacI^t$, it has become a vital tool for scientists studying glycoprotein-DNA interactions and operon regulation.

Experimental Analysis of DNA-Protein Binding

  • Experimental Scenarios: Scientists study the binding of proteins to DNA under two primary conditions:

    1. With the presence of the synthetic inducer (IPTG).
    2. Without the synthetic inducer.

  • Target DNA Sequences: The experiment involves studying the amount of protein that may bind to three distinct DNA configurations:

    1. DNA without an operator: Serving as a control to show lack of specific binding.
    2. Wild-type operator DNA ($O^+$): The standard sequence for binding comparison.
    3. $O^C$ (Constitutive Operator): The mutant DNA sequence.

  • Historical Context: The "O site" (operator) was initially defined genetically by the researchers Jacob and Monod.

  • Numerical Affinity Data: For the wild-type operator, it requires approximately 0.2 μg/mL0.2\,\mu g/mL to reach a specific binding threshold or saturation point during the calculation.

Proposed Mechanisms for Lac Repression

  • Mechanism 1: The Classical/Mutually Exclusive Model:

    • This model suggests that "lipoepressors" (lac repressors) prevent the binding of RNA polymerase to the promoter.
    • In this view, the binding of the repressor and the binding of RNA polymerase are mutually exclusive; the presence of one physically blocks the other (steric hindrance).

  • Mechanism 2: The Pseudo-Open Complex/Trapping Model:

    • This model suggests that the repressor does not prevent RNA polymerase from binding.
    • Instead, RNA polymerase and the lac repressor bind to the DNA concurrently.
    • They are trapped in an "open promoter complex confirmation" without achieving "promoter clearance."
    • Because the polymerase cannot clear the promoter, it cannot move into the elongation phase, resulting in no transcription.

One-Off Transcription Assays and Methodology

  • The Role of Azulifemcin (Rifampicin):

    • Azulifemcin (likely referring to Rifampicin) is used in these assays.
    • Once the "RPTG gene" (likely Rpt/Rif) is added, transcription initiation is halted.
    • This allows for a "one-off transcription assay" to explore specific binding and initiation events.

  • In Vitro Transcription Procedure:

    • Researchers use a piece of DNA, such as the lac alpha promoter/operator.
    • Other promoters of interest, like the example of "smart one" (likely $SmaI$), can also be used.
    • NTP Labeling: During the process, only one of the NTPs (nucleoside triphosphates) needs to be labeled to track the synthesis of the RNA.
    • The Heparin Factor: Heparin is mentioned as a component used in these biochemical assays to differentiate between binding models.

  • Experimental Observations:

    • In the absence of an inducer, RNA polymerase is trapped with the repressor, leading to "no bending" (no bands on a gel) and zero transcription elongation.
    • Upon the addition of the inducer (IPTG), the repressor releases, allowing for transcription and the appearance of the transcript.

Competing Evidence and Auxiliary Operators

  • Model Support:

    • The experiment involving trapping usually supports the "second model."
    • However, some data published approximately thirty years ago supports the "first model" (mutually exclusive binding), where the repressor's mode of blocking is to prevent the reinitiation or binding of RNA polymerase.

  • Visualizing Operator Sequences:

    • The transcript identifies multiple operator sites: $O_1$, $O_2$, and $O_3$.
    • $O_2$ is associated with the lowercase $a$, and $O_3$ is associated with $c$.
    • Uppercase designations signify sequences that are "highly cancer" (likely a transcription error for "highly conserved" or "high consensus").
    • Activity is measured specifically after the presence of IPTG to demonstrate the function of these visual or auxiliary update sequences.